The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
about
Virus-encoded homologs of cellular interleukin-10 and their control of host immune function.Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell responseMechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitiveRedefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell linesEstablishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID miceKinetics of expression of rhesus monkey rhadinovirus (RRV) and identification and characterization of a polycistronic transcript encoding the RRV Orf50/Rta, RRV R8, and R8.1 genes.trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency.Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma.A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1.Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 proteinActivation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycleIdentification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus.Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cellsHost-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programsEpstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor.Immune regulation in Epstein-Barr virus-associated diseasesDownregulation of the polyamine regulator spermidine/spermine N(1)-acetyltransferase by Epstein-Barr virus in a Burkitt's lymphoma cell line.The Epstein-Barr Virus EBNA1 Protein.The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell linesExpression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.CD21-Dependent infection of an epithelial cell line, 293, by Epstein-Barr virus.Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR.Epstein-barr virus (EBV) nuclear protein 2-induced disruption of EBV latency in the Burkitt's lymphoma cell line Akata: analysis by tetracycline-regulated expression.Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals.Expression of epstein-barr virus encoded nuclear antigen 1 in benign and malignant tissues harbouring EBV.Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes.Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency.Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders.Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection.Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas.Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells.
P2860
Q30436621-EF889B8E-471B-4CEF-860E-13D32CD247C7Q30442835-2352AC68-F6E8-4798-A230-5A3ACCB51B55Q33653017-3A696E79-D624-418C-99E4-33C45198E07AQ33783746-D9DFF9A0-AEBD-4263-9C69-06EC550CF2AEQ33784685-DE09BE5E-EC67-482E-B22C-3D2E852E6AF9Q33784983-72582496-6F75-4DC5-A6FC-32CEB6CA5E82Q34346925-1A5B3649-19E4-4686-B865-8016727CFBFAQ35363296-F8EFBF9E-3FD2-41C7-A162-0133AC1A50BCQ35798521-AB43F58B-425D-4109-B410-4DF06DD095E6Q35808018-BA94FC03-0CF2-441C-8C34-418D466F4CD4Q35839956-6637AAF4-63F9-4B4A-BF56-DC783186ED0AQ35854017-9EAD1075-22EF-4AAD-A331-3DC4860F95B1Q35859223-BC03DF3B-F6B0-4B7B-9438-A4BFA0D19D9DQ35861192-658F7F8B-B3FC-4CAE-A4BA-63FCEC9F55A4Q35872919-BE7ED577-F4AC-477C-A0FA-980073CBA893Q35873998-7BACCC84-63A8-4848-A269-41F58728E430Q36135900-ED4209D5-42B3-482F-9884-56BC14EAF272Q36564877-1801F614-9E4A-4B32-ADA9-C460675736FEQ36637195-B2375292-4784-4B34-897E-A1955C402638Q36668946-2AFE8C7C-4F49-4B9F-920A-E89B3277E2A5Q36669953-5F9DFDEF-F66A-4667-B7B7-D6518F225CDDQ37367336-F1AF05B3-9D97-4BF5-92C0-BAEFDBACF3FEQ38166365-6E6D1090-364E-4D41-AE1C-FDC466358E22Q38293055-63B1C8FD-841F-4AB7-8A29-189E466342D9Q39549997-863EA038-A715-42F9-9B0C-921630B686EEQ39551815-65D33A23-AF24-4FE7-A72D-2D86CB733362Q39556046-C700E52C-5C18-4D12-A17E-A76B196CB342Q39594354-D17072F3-BD31-4E4F-8380-05F8A4E61E1EQ39596964-0DD4221A-EBE8-451A-8ED8-29CE9694F4C7Q39599529-AC8BB967-8CB9-4D4E-8A3F-C5F08E4BC184Q40041854-D456CA43-9173-495C-83E2-D8A6DFC5A622Q40045221-DE1DA943-04A7-45EB-A021-6A1C4AC9B609Q40810034-F55281DD-4880-4F60-937B-53D04597A5C7Q42019706-A860F45B-695E-4745-81BB-3B531A0BFBCDQ42197461-E5D81C35-3C58-4344-9D19-A19D8B63F5D9Q42244791-F41796A1-ECD1-4F62-8367-A04300630EEFQ42282904-7C23F691-C7AE-46C1-8F32-A13FFB99B407
P2860
The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
The Epstein-Barr virus (EBV) n ...... B cells into the lytic cycle.
@ast
The Epstein-Barr virus (EBV) n ...... B cells into the lytic cycle.
@en
type
label
The Epstein-Barr virus (EBV) n ...... B cells into the lytic cycle.
@ast
The Epstein-Barr virus (EBV) n ...... B cells into the lytic cycle.
@en
prefLabel
The Epstein-Barr virus (EBV) n ...... B cells into the lytic cycle.
@ast
The Epstein-Barr virus (EBV) n ...... B cells into the lytic cycle.
@en
P2093
P2860
P1433
P1476
The Epstein-Barr virus (EBV) n ...... B cells into the lytic cycle.
@en
P2093
P2860
P304
P407
P577
1992-12-01T00:00:00Z